November 2017

Important New Products

• Antizol (fomepizole) is a competitive inhibitor of alcohol dehydrogenase. Alcohol ...(more)

New Indications

• Fraxiparine (nadroparin calcium) is now indicated for prophylaxis of venous thromboembolism ...(more)
• Keytruda (pembrolizumab (rch)) as monotherapy is now indicated for the treatment of adults...(more)

New Contraindications

• Invirase (saquinavir) is now contraindicated with concomitant rilpivirine, dasatinib or ...(more)
• Mersyndol and Panalgesic (paracetamol, codeine phosphate hemihydrate and doxylamine ...(more)
• Mersyndol DayStrength, Panamax Co, Prodeine and Prodeinextra (paracetamol, codeine ...(more)
• Navelbine (vinorelbine tartrate) is now contraindicated with neutrophil count < 1500 cells/mm³, ...(more)
• Neulactil (periciazine) is now contraindicated with previous history of agranulocytosis, risk ...(more)
• Proctosedyl (cinchocaine hydrochloride, hydrocortisone) is now contraindicated in bacterial, ...(more)
• Zomacton (somatropin (rbe)) treatment should be discontinued at renal transplantation in ...(more)

Active Ingredient Naming Changes

In this release, MIMS Australia will be including the following INNs (International Non-proprietary Names) as well as Australian Approved Names (AANs) as part of our push to support the Therapeutic Goods Administration (TGA) active ingredient name changes project.  

MIMS will begin referring to these ingredients by their new names, however, users may continue to search by the old AANs if preferred. ...(more)